Scilex Holding (SCLX) Return on Capital Employed (QoQ) (2021 - 2026)

Scilex Holding (SCLX) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Scilex Holding 54.30 Mn -95.62 Mn 4.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -886.00
Dec 31, 2025 6,500.00
Sep 30, 2025 10,392.00
Jun 30, 2025 -532.00
Mar 31, 2025 -280.00
Dec 31, 2024 1,021.00
Sep 30, 2024 -1,758.00
Jun 30, 2024 -501.00
Mar 31, 2024 -256.00
Dec 31, 2023 -1,929.00
Sep 30, 2023 302,592.00
Jun 30, 2023 -263,018.00
Mar 31, 2023 -20,731.00
Dec 31, 2022 -4,841.00
Sep 30, 2022 -1,506.00
Jun 30, 2022 110.00
Mar 31, 2022 -9,976.00
Dec 31, 2021 5,955.00
Sep 30, 2021 -20.00